Proteomics Intl Labs Ltd has released a press release.
Proteomics targets gastro-causing parasite
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Earlier from Proteomics International Laboratories
- Proteomics International receives FY16 R&D Tax Incentive
- Proteomics investigates biomarkers for mesothelioma
- Proteomics expands diagnostics portfolio to endometriosis
- Proteomics first commercialisation deal for PromarkerD
- Appendix 4C - June 2016 Quarterly Report
Later from Proteomics International Laboratories
- Appendix 4C - September 2016 Quarterly Report
- PromarkerD test kit production deal signed
- Proteomics and Linear partner in testing and clinical trials
- Proteomics completes $1.44 million Placement and offers SPP
- PromarkerD shows improved predictive ability and robustness
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories